Explore 3 Stock Ideas & Industry Insights Download Free Report

Avant Technologies Inc.

Company price
0.088 USD -0.00 ( 0.23%)
Last update at 2026-11-10T20:20:00Z
VOLUME
6000
Market Cap
40.09M

Momentum Score

…

Avaí Bio, Inc. acquires, creates, and develops artificial intelligence (AI) technologies. It also offers information technology (IT) consulting services. The company provides full-stack software development, database management, data integration, project management and cloud services resources. Further, it offers Avant! AI, a platform that has shown impressive results related to the technology's usage, access, and performance; and InstantFAME. The company was formerly known as Avant Technologies Inc. and changed its name to Avaí Bio, Inc. in February 2026. Avaí Bio, Inc. was incorporated in 2017 and is based in Vilnius, Lithuania.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.09
Low
0.09
High
52 Week Price Range
0.25
Low
0.83
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Publicly listed on the OTCQB, Avant Technologies Inc is a small-cap company for which public filings and disclosures provide limited detail about its core operations and product offerings. Given scarce public information, long-term growth drivers are uncertain but may depend on successful execution of disclosed plans, ability to raise capital, and progress toward commercial traction, which could appeal to investors seeking early-stage technology exposure.

Key investment risks include limited transparency and disclosure, low liquidity and heightened share-price volatility common to OTC stocks, possible lack of revenue or profitability, and significant financing and execution risk.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.09
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
-
ROE
-
Net Debt
0.82M
ROCE
73.03%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Income before tax -1.14M -2.13M -0.35M -0.13M -0.25M
Net income -1.14M -2.13M -0.35M -0.13M -0.25M
Selling general administrative 1.44M 2.02M 0.30M 0.51M 0.18M
Gross profit - 0.00M -0.04M 0.21M -0.02M
Reconciled depreciation 0.07M 0.08M 0.02M 0.04M 0.05M
Ebit - - - -0.13M -0.30M
Ebitda - - -0.33M -0.08M -0.19M
Operating income -1.14M -2.13M -0.35M -0.13M -0.25M
Other operating expenses - - - -0.22M -0.00M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Total revenue 0.00M 0.00M 0.28M 0.92M 1.21M
Total operating expenses 1.14M 2.13M 0.63M 1.05M 1.46M
Cost of revenue - 0.00M 0.32M 0.71M 1.23M
Total other income expense net - - - - 0.00M
Net income from continuing ops -1.14M -2.13M -0.35M -0.13M -0.25M
Net income applicable to common shares - - - -0.13M -0.30M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 0.22M 0.32M 0.24M 0.45M 0.87M
Intangible assets 0.13M 0.21M 0.13M 0.12M 0.17M
Total liab 1.79M 1.79M 0.87M 0.86M 1.14M
Total stockholder equity -1.56M -1.47M -0.63M -0.41M -0.28M
Deferred long term liab - - - - 0.00M
Other current liab - - - 0.06M 0.38M
Common stock - - - 0.03M 0.03M
Capital stock 0.16M 0.14M 0.04M 0.03M 0.03M
Retained earnings -4.12M -2.98M -0.85M -0.50M -0.37M
Other assets - - - - 0.00M
Cash 0.08M 0.00M 0.11M 0.03M 0.06M
Total current liabilities 1.79M 1.79M 0.87M 0.86M 1.14M
Net debt 0.82M 0.71M 0.53M 0.57M 0.36M
Short long term debt 0.90M 0.71M 0.64M 0.60M 0.42M
Other stockholder equity - - - -0.00M 0.01M
Property plant equipment - - - 0.00M 0.02M
Total current assets 0.09M 0.12M 0.11M 0.33M 0.62M
Net tangible assets - - - -0.53M -0.50M
Net receivables - - 0.00M 0.17M 0.35M
Inventory - - - - 0.00M
Accounts payable 0.89M 1.08M 0.04M 0.00M 0.27M
Non current assets total 0.13M 0.21M 0.13M 0.12M 0.20M
Capital lease obligations - - - - 0.00M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Investments 0.00M -0.15M -0.03M 0.03M 0.02M
Change to liabilities - - - -0.27M 0.22M
Total cashflows from investing activities - - - 0.03M 0.02M
Net borrowings 0.20M 0.07M - 0.47M 0.03M
Total cash from financing activities 1.24M 1.36M 0.16M 0.47M 0.03M
Change to operating activities - - - -0.23M -0.02M
Net income -1.14M -2.13M -0.35M -0.13M -0.30M
Change in cash 0.08M -0.11M 0.07M -0.03M 0.03M
Begin period cash flow 0.00M 0.11M 0.03M 0.06M 0.03M
End period cash flow 0.08M 0.00M 0.11M 0.03M 0.06M
Total cash from operating activities -1.16M -1.32M -0.05M -0.54M -0.02M
Issuance of capital stock 1.04M 1.30M 0.12M 0.00M 0.00M
Depreciation 0.07M 0.08M 0.02M 0.04M 0.05M
Other cashflows from investing activities - - - 0.03M 0.02M
Change to inventory - - - 0.00M 0.00M
Change to account receivables - 0.00M 0.00M 0.06M -0.03M
Change to netincome - - - -0.01M 0.06M
Capital expenditures 0.00M 0.15M 0.03M 0.00M 0.00M
Change in working capital -0.09M 0.73M 0.27M -0.43M 0.17M
Free cash flow -1.16M -1.47M -0.09M -0.54M -0.02M

Peer Comparison*

Sector: Technology Industry: Software - Application

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
AVAI
Avant Technologies Inc.
-0.00
0.23%
0.09 - - 181.14 2153.43 223.21 -40.35
SAP
SAP SE ADR
-
-%
233.74 28.16 22.42 6.52 4.85 5.60 16.61
CRM
Salesforce Inc
-1.46
0.68%
213.48 23.41 15.55 4.79 5.56 5.55 14.88
SAPGF
SAP SE
-5.80
2.44%
232.20 76.28 22.88 5.61 3.84 5.59 26.18
SHOP
Shopify Inc
-5.46
3.59%
146.60 90.18 53.19 12.70 13.17 12.23 67.86

Profile*

Avant Technologies Inc.

Avaí Bio, Inc. acquires, creates, and develops artificial intelligence (AI) technologies. It also offers information technology (IT) consulting services. The company provides full-stack software development, database management, data integration, project management and cloud services resources. Further, it offers Avant! AI, a platform that has shown impressive results related to the technology's usage, access, and performance; and InstantFAME. The company was formerly known as Avant Technologies Inc. and changed its name to Avaí Bio, Inc. in February 2026. Avaí Bio, Inc. was incorporated in 2017 and is based in Vilnius, Lithuania.

Sv. Stepono g. 27D-2, Vilnius, Lithuania

866 533 0065

Name Title Year Born
Mr. Ivan Lunegov President & Director 1986
Ms. Natalija Tunevic Secretary 1958
Mr. Vitalis Racius CFO, Director & Treasurer 1982
Mr. Kenneth L. Waggoner Esq. Chief Executive Officer 1948
Mr. Chris Winter Chief Operating Officer NA
Dr. Danny Rittman Ph.D. Chief Information Security Officer 1963
Mr. Chris Winter Chief Executive Officer 1963
Ms. Natalija Tunevic Secretary 1959

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…